The role of Pim kinase in immunomodulation.

Abstract

Pim kinase, which has three isozymes (Pim-1, Pim-2 and Pim-3), is a serine/threonine kinase abnormally expressed in many cancers. High Pim kinase expression has been recognized to be associated with disease progression and prognosis. It is well accepted that Pim kinase is considered a clinical biomarker and potential therapeutic target for tumor cell. In recent years, researches verified the role of Pim kinase in immunomodulation. The mechanisms by which Pim kinase modulates the immune microenvironment and regulates immune cells, as well as the effects of Pim kinase inhibitors on immunity, have not been systematically described. This review comprehensively focuses on the current research status of Pim kinase pathways and the immune regulation.

• Authors: Zhaoyun Liu, Mei Han, Kai Ding, Rong Fu
• Journal: American journal of cancer research (Am J Cancer Res) Vol. 10 Issue 12 Pg. 4085-4097 ( 2020) ISSN: 2156-6976 [Print] United States
• PMID: 33414987 (Publication Type: Journal Article, Review)
• Copyright: AJCR Copyright © 2020.